These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 5955616

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Late effects among Hiroshima and Nagasaki survivors.
    Warren S.
    Lahey Clin Found Bull; 1968; 17(1):1-5. PubMed ID: 5636899
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV, Prentice RL, Ishimaru T, Kato H, Mason M.
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [Abstract] [Full Text] [Related]

  • 28. Radiation of Hiroshima and Nagasaki builds foundation for risk estimates.
    Ketchum LE.
    J Nucl Med; 1985 Aug; 26(8):833-6. PubMed ID: 3897479
    [No Abstract] [Full Text] [Related]

  • 29. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. E. Cancers other than leukemia.
    Beebe GW, Kato H.
    J Radiat Res; 1975 Sep; 16 Suppl():97-107. PubMed ID: 1195207
    [No Abstract] [Full Text] [Related]

  • 30. [STATISTICAL OBSERVATIONS DURING THE PAST 5 YEARS ON HIROSHIMA ATOMIC BOMB CASUALTIES WHO ENTERED THE CITY WITHIN 3 DAYS AFTER EXPLOSION. (1)].
    SHIMIZU K, WATANABE M, ITO S, YAMAMOTO O.
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:36-45. PubMed ID: 14146157
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Delayed radiation effects in atomic-bomb survivors. Major observations by the Atomic Bomb Casualty Commission are evaluated.
    Miller RW.
    Science; 1969 Oct 31; 166(3905):569-74. PubMed ID: 4898614
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D.
    Stem Cells; 1995 May 31; 13 Suppl 1():40-8. PubMed ID: 7488967
    [Abstract] [Full Text] [Related]

  • 38. [A new assessment of the data from Hiroshima and Nagasaki].
    Kellerer AM.
    Strahlenschutz Forsch Prax; 1988 May 31; 30():63-91. PubMed ID: 3222810
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The atomic bomb survivors and the problem of low-dose radiation effects.
    Beebe GW.
    Am J Epidemiol; 1981 Dec 31; 114(6):761-83. PubMed ID: 7032282
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.